Thyroid hormone and estradiol modulate biological processes by binding to nuclear receptor proteins that, through interactions with specific response elements in the regulatory regions of genes, modulate gene transcription. Both the estrogen receptor (ER) and thyroid hormone receptor (TR) are members of the nuclear receptor superfamily (Evans, 1988; Zhangand Lazar, 2000). These receptors have a modular protein structure with high homology in the central DNA binding domain (Yen, 2001) . The DNA-binding domain is the most conserved region of the nuclear receptor superfamily responsible for targeting the receptor to highly specific DNA sequences comprising a response element. It is known that ERs bind target response elements with two consensus AGGTCA motifs in a palindromic array with a 3-bp spacer (Trussand Beato, 1993). However, it has been demonstrated that the same AGGTCA motifs but in other orientations serve as targets for TRs (Yenand Chin, 1994). Published studies also indicate that there are two major TR subtypes, TRα-and TRβ-encoded, on separate genes (Lazar, 1993). With alternative splicing, three functional isoforms, TRα1, TRβ1, and TRβ2, have been identified. The ER exists in two isoforms, α and β, which are products of different genes showing promoter site specificity (Kuiper et al. 1996) .
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It is known that thyroid hormones have major effects on the female reproductive system (Gardner et al. 1978) . They are critical for growth, development and differentiation. However, there is insufficient evidence on interactions of these hormones with sex steroids in the cells of reproductive tissues. In order to gain more information about the relationship between thyroid and estrogen hormone actions, we studied receptor binding parameters for both kinds of analyzed hormones, as well as the competition in binding of these hormones to nuclear receptors in the rat uterus.
Adult female rats of the Wistar strain (200-220 g b.w.) were used 
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for the experiments. Animals were ovariectomized seven days before experiments. Nuclear extracts were prepared according to the methods of Evans et al. (1983) . The animals were killed by decapitation, and the uteri were minced and homogenized in TEMG buffer (50 mM TrisHCl, 1 mM EDTA, 12 mM monothioglycerol, 30% glycerol, pH 7.5) using an Ultra-Turrax homogenizer (3x30 sec). The homogenate was filtered through four layers of gauze and centrifuged at 800xg for 15 min at 4 0 C. The resultant pellet was washed by resuspension and centrifugation twice in TMG buffer (20 mM Tris-HCl, 12 mM monothioglycerol, 10% glycerol, pH 7.5) containing 0.2% Triton X-100 and once with TMG buffer alone. The washed nuclear pellet was then resuspended in TEMG buffer containing 0.5 M KCl and mixed at 15-min intervals for 1 h. After centrifugation at 100.000xg for 1 h at 4 0 C, the obtained supernatant (nuclear extract) was used in the binding studies.
Equilibrium binding studies were done by incubating aliquots of nuclear extracts with increasing concentrations of [2, 4, 6, H(N)]-estradiol (SA 71 Ci/mmol, Perkin Elmer Life Sciences Inc., Boston, MA) ranging from 0.125 to 10 nM, or 125 I-triiodothyronine ( 125 IT 3 ) (SA 67 µCi/µg, Radioisotope Laboratory, Vinča Institute of Nuclear Sciences) ranging from 0.12 to 7 nM in the absence (total binding) or in the presence (non-specific binding) of a 1000-fold excess of unlabeled hormones, diethylstilbestrol (Des) or triiodothyronine (T 3 ). After incubation, bound and free hormones were separated using the dextran-charcoal absorption binding technique. Receptor binding parameters such as the dissociation constant (Kd) and number of binding sites (N) for both kinds of hormones were determined by Scatchard plot analyses (Scatchard, 1949) using a computer program. Competition assays were done by incubating aliquots of nuclear extracts with a single concentration of labeled hormones and varying the concentration of unlabeled competitors (1x10 -9 -1x10 -4 M) for 2 h at 23 0 C. Protein concentration was measured by the method of Lowry et al. (1951) .
The obtained results provide evidence for the presence of specific receptors for both analyzed hormones. Binding properties of rat uterus estrogen and thyroid hormone receptors are shown by representative saturation curves and Scatchard plots in Fig. 1 . The data indicate the presence of a single class (linear Scatchard plot) of saturable and highaffinity binding sites for both kinds of hormones. The Kd values (Figs.1B and 1D ) are in the range observed for 3 HE and 125 IT 3 binding in other mammalian tissues (Evans et al. 1983) . The results of our study also indicate a limited capacity of those binding sites. The T 3 receptor concentration in rat uterus nuclei was much lower in comparison with the concentration of estrogen receptors in the same tissue. This is in agreement with previously published data (Evans et al. 1983; Mukku et al. 1983 ) that indicate a small number of T 3 receptors in rat uterus nuclei. Moreover, there are more high-affinity binding sites for T 3 , which are responsible for the expected biological effects, in the liver and kidney, than in the uterus (Evans et al. 1983) .
Since these studies indicate the presence of saturable and highaffinity binding sites in uterine nuclear extracts, binding specificity of these receptors was analyzed using the competitive equilibrium binding method. The results of competition studies are shown in Fig. 2 .
Competition experiments revealed that 3 HE binding in the nuclear extracts was markedly reduced by the presence of a 1000-fold molar excess of unlabeled Des, but was not reduced by the presence of an equivalent molar excess of unlabeled T 3 (Fig. 2 A) . Similar reduction of 125 IT 3 binding was observed in the presence of a 1000-fold molar excess of unlabeled T 3 , and there was no competition by Des for 125 IT 3 binding (Fig. 2 B) .
Taken together, the data presented herein confirm the presence of specific, high-affinity binding sites for the analyzed hormones in rat uterus, as well as no competition between these two hormones at the receptor-binding level. The mechanisms responsible for the interaction between estadiol and thyroid hormones are not yet known.
In vitro and in vivo data indicate that manipulations of estrogen and thyroid hormone levels can alter each other's functions. One possible mechanism for interaction may be that thyroid and estrogen receptors, having structural similarities, bind to an identical half-site, AGGTCA, of their cognate hormone response elements and thereby can compete with each other at this level (Vasudevan et al. 2002) . It follows that thyroid hormones and estrogen can interact through their own receptors in several different modes, depending on TR and ER isoforms, hormone response elements, and the gene promoter and cell type.
